Biosimilars: Not Our First Rodeo
June 13, 2023
Americans spend the most money on prescription drugs compared to every other country in the world. Perhaps of more significance is that the cost of
Posts in category: Specialty Drugs
Do You Know How Your PBM Handles Specialty Drugs?
June 14, 2022
Specialty drugs make up 30-40% of plan spending. Specialty drugs are often expensive, but critical to treat the condition for which they are prescribed. In
Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs
January 14, 2019
Europeans have found the secret to making some of the world’s costliest medicines much more affordable, as much as 80 percent cheaper than in the
Cholesterol Drug’s List Price Will Be Reduced By More Than Half
November 6, 2018
Amgen has announced that it will reduce the price of its cholesterol drug evolocumab (Repatha) by 60% from its annual list price of $14,100, according
Gilead to Sell Authorized Generic Versions of Hep C Treatments
October 9, 2018
Officials with Gilead Sciences, Inc. plan to launch authorized generic versions of sofosbuvir 400 mg/velpatasvir 100 mg (Epclusa) and ledipasvir 90mg/sofosbuvir 400 mg (Harvoni), Gilead’s leading
Prescription drug prices rising despite Trump pressure on Big Pharma
October 9, 2018
President Donald Trump made reducing drug prices a key promise during his election campaign, repeatedly accusing drugmakers of “getting away with murder.” At the end
Want to Save a Billion Dollars? Avoid Combo Meds
September 12, 2018
(Written by F. Perry Wilson, MD, MSCE) This week: Would you like to save about a billion dollars? This article, appearing in the Journal of the American
TV commercials for prescription drugs ‘doing more harm than good’
April 11, 2018
There are few more brazen examples of healthcare practices that put industry profits ahead of patient interests than hawking prescription drugs in cheerful, 60-second
